Adipocytokines in Down's syndrome, an atheroma-free model: Role of adiponectin

Archives of Gerontology and Geriatrics

Volumn 48, Issue 1, 2009, Pages 106-109

  Corsi, Massimiliano M ^a,b   Dogliotti, Giada ^a   Pedroni, Francesca ^a   Galliera, Emanuela ^a   Malavazos, Alexis E ^a   Villa, Roberto ^a   Chiappelli, Martina ^c   Licastro, Federico ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Adiponectin; Down's syndrome; Interleukin 6; Leptin; Tumor necrosis factor high sensitivity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; DOWN SYNDROME; GROUPS BY AGE; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

ADIPOKINES; ADIPONECTIN; ADOLESCENT; ADULT; AGING; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; INTERLEUKIN-6; ITALY; LEPTIN; MIDDLE AGED; MODELS, CARDIOVASCULAR; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 56949085755     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2007.10.011     Document Type: Article

References (18)

1. Antonelli A., Bracci-Laudiero L., and Aloe L. Altered plasma nerve growth factor-like immunoreactivity and nerve growth factor-receptor expression in human old age. Gerontology 49 (2003) 185-190
2. Baird P.A., and Sadovnick A.D. Causes of death to age 30 in Down syndrome. Am. J. Hum. Genet. 43 (1988) 239-248
3. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 189 (2006) 47-60
4. Fantuzzi G. Leptin: nourishment for the immune system. Eur. J. Immunol. 36 (2006) 3101-3104
5. Fantuzzi G., and Mazzone T. Adipose tissue and atherosclerosis: exploring the connection. Arterioscl. Thromb. Vas. 27 (2007) 996-1003
6. Franceschi C., Licastro F., Chiricolo M., Bonetti F., Zannotti M., Fabris N., Mocchegiani E., Fantini M.P., Paolucci P., and Masi M. Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down's syndrome. J. Immunol. 126 (1981) 1264-2161
7. Guzik T.J., Mangalat D., and Korbut R. Adipocytokines: novel link between inflammation and vascular function?. J. Physiol. Pharmacol. 57 (2006) 505-528
8. Hopkins W.E., Fukagawa N.K., Sobel B.E., and Schneider D.J. Plasminogen activator inhibitor type 1 in adults with Down syndrome and protection against macrovascular disease. Am. J. Cardiol. 85 (2000) 784-786 A789
9. Licastro F., Mariani R.A., Faldella G., Carpenè E., Guidicini G., Rangoni A., Grilli T., and Bazzocchi G. Immune-endocrine status and coeliac disease in children with Down's syndrome: relationships with zinc and cognitive efficiency. Brain Res. Bull. 55 (2001) 313-317
10. Licastro F., Chiappelli M., Ruscica M., Carnelli V., and Corsi M.M. Altered cytokine and acute phase response protein levels in the blood of children with Down syndrome: relationship with dementia of Alzheimer's type. Int. J. Immunopathol. Pharmacol. 18 (2005) 165-172
11. Licastro F., Marocchi A., and Penco S. Does Down's syndrome support the homocysteine theory of atherogenesis? Experience in elderly subjects with trisomy 21. Arch. Gerontol. Geriatr. 43 (2006) 381-387
12. Licastro F., Chiappelli M., Porcellini E., Trabucchi M., Marocchi A., and Corsi M.M. Altered vessel signalling molecules in subjects with Downs syndrome. Int. J. Immunopathol. Pharmacol. 19 (2006) 181-185
13. Licastro F., Dogliotti G., Goi G., Malavazos A.E., Chiappelli M., and Corsi M.M. Oxidated low-density lipoproteins (oxLDL) and peroxides in plasma of Down syndrome patients. Arch. Gerontol. Geriatr. 44 (2007) 225-232
14. Kougias P., Chai H., Lin P.H., Yao Q., Lumsden A.B., and Chen C. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J. Surg. Res. 126 (2005) 121-129
15. Mikkelsen M. Epidemiology of trisomy 21: population, peri- and antenatal data. Hum. Genet. 2 (1981) 211-226
16. Murdoch J.C., Rodger J.C., Rao S.S., Fletcher C.D., and Dunnigan M.G. Down's syndrome: an atheroma-free model?. Br. Med. J. 2 (1977) 226-228
17. Pueschel S.M., Craig W.Y., and Haddow J.E. Lipids and lipoproteins in persons with Down's syndrome. J. Intellect. Disabil. Res. 36 (1992) 365-369
18. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772